References
- ICS-tuberculosis working group. A seven-year epidemiological review of tuberculosis in the circumpolar region 2006-2012. Available from: htpp://dhss.alaska.gov/dph/Epi/id/SiteAssets/Pages/TB/ICS-TB_report_2006-2012.pdf
- Alaska Epidemiology Recommendations and Reports. Alaska’s ongoing journey with tuberculosis in Alaska and considerations for future control. Vol. 19, No. 1, April 11, 2017. Available from: htpp://www.epi.alaska.gov/bulletin/docs/rr2017_1.pdf
- Schwartz NG, Price SF, Pratt RH, et al. Tuberculosis-USA, 2019. MMWR More Mortal Rep. 2020;69:286–4. .
- Comstock GW. Isoniazid prophylaxis in an underdeveloped area. Am Rev Respir Dis. 1962;21:9–27.
- Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Eng J Med. 2010;363:1005–1015.
- Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect. 2012;64:580–588.
- CDC. Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistance strains, and considerations for its use-USA, 2013. MMWR Morg Mortal Wkly Rep. 2013;62:821–824.
- Choi HW, Miele K, Dowdy D, et al. Cost effectiveness of Xpert MTB/RIF for diagnosing pulmonary tuberculosis in the USA. Int J Tuberc Lung Dis. 2013;17:1328–1335.
- Bowerman RJ. The promise of rapid detection of active pulmonary tuberculosis in rural Alaska. Alaska Med. 2015;56:24–28.
- Nahid P, Dorman SE, Alipanah N, et al. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: diagnosis of tuberculosis in adults and children. CID. 2017;64:1–33.
- Ampel NM Diagnosing TB with the Xpert assay vs AFB smear microscopy (reviewing Lee H-S, et al Am J Resp Crit Care Med 2019 Mar 15). Available from: htpps://www.jwatch.org/na48799/2019/03/25/diagnosing-tb-with-xpert-assay-vs-afb-snear-microscopy
- Mathew P, Yen-Hong K, Vaxirani B, et al. Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation? J Clin Microbiol. 2002;40:3482–3484.
- Park PH, Holland DP, Wade A, et al. Public health costs for tuberculosis suspects in Wake County, North Carolina, USA. Int J Tuberc Lung Dis. 2013;17:759–763.
- Chaisson LH, Roemer M, Cantu D, et al. Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial. CID. 2014;59:1353–1360.
- Chaisson LH, Duong D, Cattamanchi A, et al. Association of rapid molecular testing with duration of respiratory isolation for patients with possible tuberculosis in a US hospital. JAMA Intern Med. 2018;178:1380–1388.
- Adam P, Pai M. Editorial-Implementation of Xpert MTB/RIF in high-burden countries: voices from the field matter. PHA. 2019;9:78–79.